387 related articles for article (PubMed ID: 4369887)
1. Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.
Klein G; Lindahl T; Jondal M; Leibold W; Menézes J; Nilsson K; Sundström C
Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3283-6. PubMed ID: 4369887
[TBL] [Abstract][Full Text] [Related]
2. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus: detection of genome in somatic cell hybrids of Burkitt lymphoblastoid cells.
Glaser R; Nonoyama M
Science; 1973 Feb; 179(4072):492-3. PubMed ID: 4350214
[TBL] [Abstract][Full Text] [Related]
4. New method for detecting Epstein-Barr virus association in nonproducer lymphoblastoid cell lines.
Giunta S; Groppa G
Cancer Res; 1983 Nov; 43(11):5064-7. PubMed ID: 6311404
[TBL] [Abstract][Full Text] [Related]
5. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus gene expression during primary B-lymphocyte infection, in transformed and Burkitt lymphoma-derived cell lines.
Ernberg I; Kallin B; Dillner J
Curr Top Microbiol Immunol; 1986; 132():251-6. PubMed ID: 3024918
[No Abstract] [Full Text] [Related]
7. Epstein-Barr virus DNA in human lymphoid cell lines: in vitro conversion.
Andersson M; Lindahl T
Virology; 1976 Aug; 73(1):96-105. PubMed ID: 183361
[No Abstract] [Full Text] [Related]
8. Immunobiology of Epstein-Barr virus-associated lymphomas.
Rochford R; Mosier DE
Clin Immunol Immunopathol; 1994 Jun; 71(3):256-9. PubMed ID: 8200127
[No Abstract] [Full Text] [Related]
9. Epstein-Barr virus genome studies in Burkitt's and non-Burkitt's lymphomas in Uganda.
Olweny CL; Atine I; Kaddu-Mukasa A; Owor R; Andersson-Anvret M; Klein G; Henle W; de-Thé G
J Natl Cancer Inst; 1977 May; 58(5):1191-6. PubMed ID: 192894
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus in lymphomas: a review.
Joske D; Knecht H
Blood Rev; 1993 Dec; 7(4):215-22. PubMed ID: 8130684
[No Abstract] [Full Text] [Related]
11. Demonstration of Epstein-Barr virus in malignant non-Hodgkin's lymphomas.
Wutzler P; Färber I; Sauerbrei A; Helbig B; Wutke K; Rüdiger KD; Scheibner K; Brichàcek B; Vonka V
Oncology; 1986; 43(4):224-9. PubMed ID: 2425318
[TBL] [Abstract][Full Text] [Related]
12. [Expression of latent membrane proteins (LMP) of Epstein-Barr virus in malignant lymphomas].
Herbst H; Dallenbach F; Niedobitek G; Anagnostopoulos I; Hummel M; Finn T; Jautzke G; Müller-Lantzsch N; Stein H
Verh Dtsch Ges Pathol; 1991; 75():175-8. PubMed ID: 1724825
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
Menezes J; Leibold W; Klein G; Clements G
Biomedicine; 1975 Jul; 22(4):276-84. PubMed ID: 179629
[TBL] [Abstract][Full Text] [Related]
14. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus in an American patient with Burkitt's lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line (NAB).
Gravell M; Levine PH; McIntyre RF; Land VJ; Pagano JS
J Natl Cancer Inst; 1976 Apr; 56(4):701-4. PubMed ID: 176407
[TBL] [Abstract][Full Text] [Related]
16. Effect of hydrocortisone on cell viability, Epstein-Barr virus genome expression, and interferon synthesis in human lymphoblastoid cell lines.
Joncas J; Boucher J; Boudreault A; Granger-Julien M
Cancer Res; 1973 Sep; 33(9):2142-8. PubMed ID: 4353485
[No Abstract] [Full Text] [Related]
17. An Epstein-Barr virus-negative B lymphoma cell line (THP-2) from a Burkitt's lymphoma of a Japanese patient.
Tsuchiya S; Yamaguchi Y; Kobayashi Y; Minegishi M; Imaizumi M; Suzuki H; Konno T; Tada K
Tohoku J Exp Med; 1983 Aug; 140(4):429-34. PubMed ID: 6314596
[TBL] [Abstract][Full Text] [Related]
18. Examination of Epstein-Barr virus and C-type proviral sequences in American and African lymphomas and derivative cell lines.
Pizzo PA; Chattopadhyay SK; Magrath IT; Del Giacco E; Sherrick D; Gray T
Cancer Res; 1981 Aug; 41(8):3165-71. PubMed ID: 6265077
[TBL] [Abstract][Full Text] [Related]
19. Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines.
Delecluse HJ; Bartnizke S; Hammerschmidt W; Bullerdiek J; Bornkamm GW
J Virol; 1993 Mar; 67(3):1292-9. PubMed ID: 8382295
[TBL] [Abstract][Full Text] [Related]
20. Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies.
Lindahl T; Klein G; Reedman BM; Johansson B; Singh S
Int J Cancer; 1974 Jun; 13(6):764-72. PubMed ID: 4137165
[No Abstract] [Full Text] [Related]
[Next] [New Search]
